B-Lymphocyte Stimulator (BLyS) To Treat Selective IgA Deficiency

NCT00024934 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

NIH

Sponsor class

Conditions

IgA Deficiency

Interventions

DRUG: B-Lymphocyte Stimulator (BLyS)

Sponsor

National Cancer Institute (NCI)